The Epidemic is Not Over: Updates on Opioids
Benjamin Lai, M.B., B.Ch., B.A.O., Erin F. Morcomb, M.D., Glenn R. Kauppila, D.O., Christopher J. Arendt, Pharm.D., R.Ph.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Summarize recent legal & regulatory changes related to opioid prescribing, opioid use disorder (OUD) screening for treatment.
• Identify current opioid prescribing metrics. Screen & identify patients with OUD and offer early intervention & treatment.
• Explain key components of the 2022 CDC opioid prescribing guidelines.
• Recognize when to prescribe naloxone, and how best to counsel patients and their families on the use of naloxone. Identify local resources for treatment of chronic pain and OUD.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.